Location History:
- Bourg Achard, FR (1991)
- Fontenay aux Roses, FR (1995 - 1997)
Company Filing History:
Years Active: 1991-1997
Title: Corinne Rousselle: Innovator in Cerebral Disorder Treatments
Introduction
Corinne Rousselle is a prominent inventor based in Fontenay aux Roses, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cerebral disorders. With a total of 5 patents to her name, Rousselle's work is recognized for its innovative approach to complex medical challenges.
Latest Patents
Among her latest patents is the compound N-(3-Aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide. This compound is designed to address various cerebral disorders through its unique chemical structure. Another notable patent is 3-(2-aminomethyl)-4-[3-trifluoromethyl)benzoyl]-3-4, which also targets the treatment and prevention of cerebral disorders. These inventions showcase her dedication to advancing medical science and improving patient outcomes.
Career Highlights
Corinne Rousselle has built a successful career at Synthelabo, where she has been instrumental in developing innovative pharmaceutical solutions. Her expertise in medicinal chemistry has led to breakthroughs that are vital for treating neurological conditions. Rousselle's commitment to research and development has positioned her as a leader in her field.
Collaborations
Throughout her career, Rousselle has collaborated with esteemed colleagues, including Jonathan Reid Frost and Pascal George. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Corinne Rousselle's contributions to the field of pharmaceuticals, particularly in treating cerebral disorders, highlight her as a key figure in medical innovation. Her patents reflect a commitment to improving health outcomes through scientific advancement.